|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 47/32 | (2006.01) |
| A61K 47/32 | (2013.01) | ||
| A61K 9/14 | (2006.01) | ||
| A61K 9/10 | (2013.01) | ||
| A61K 31/557 | (2006.01) | ||
| A61K 45/06 | (2013.01) | ||
| A61K 9/10 | (2006.01) | ||
| A61K 31/785 | (2013.01) | ||
| A61P 9/12 | (2006.01) | ||
| A61K 47/585 | (2017.08) | ||
| A61K 31/192 | (2013.01) | ||
| A61P 11/00 | (2018.01) | ||
| A61P 43/00 | (2018.01) | ||
| A61P 9/10 | (2018.01) | ||
| A61P 9/12 | (2018.01) |
| (11) | Patento numeris | 3164155 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 15731463.4 |
| Europos patento paraiškos padavimo data | 2015-06-12 | |
| (97) | Europos patento paraiškos paskelbimo data | 2017-05-10 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2022-02-09 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2015/035595 |
| Data | 2015-06-12 |
| (87) | Numeris | WO 2015/192030 |
| Data | 2015-12-17 |
| (30) | Numeris | Data | Šalis |
| 201462011689 P | 2014-06-13 | US |
| (72) |
PHARES, Ken , US
CHANG, Courtney , US
|
| (73) |
United Therapeutics Corporation ,
1040 Spring Street, Silver Spring, MD 20910,
US
|
| (54) | TREPROSTINIL FORMULATIONS |
| TREPROSTINIL FORMULATIONS |